PERTILE, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 1.907
EU - Europa 1.774
AS - Asia 1.091
SA - Sud America 143
AF - Africa 20
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.942
Nazione #
US - Stati Uniti d'America 1.878
GB - Regno Unito 505
IT - Italia 442
SG - Singapore 422
CN - Cina 396
HK - Hong Kong 155
DE - Germania 139
RU - Federazione Russa 139
FR - Francia 133
BR - Brasile 132
IE - Irlanda 116
SE - Svezia 109
FI - Finlandia 94
KR - Corea 26
UA - Ucraina 25
VN - Vietnam 17
CA - Canada 15
NL - Olanda 14
BE - Belgio 12
IN - India 10
TR - Turchia 10
ID - Indonesia 9
TG - Togo 9
BD - Bangladesh 8
PT - Portogallo 8
ES - Italia 7
MX - Messico 7
AT - Austria 6
CZ - Repubblica Ceca 6
IQ - Iraq 6
AU - Australia 5
IR - Iran 5
SA - Arabia Saudita 5
CO - Colombia 4
AL - Albania 3
DK - Danimarca 3
EG - Egitto 3
JP - Giappone 3
KZ - Kazakistan 3
PL - Polonia 3
SY - Repubblica araba siriana 3
UG - Uganda 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
GR - Grecia 2
JM - Giamaica 2
JO - Giordania 2
MA - Marocco 2
TH - Thailandia 2
AO - Angola 1
AR - Argentina 1
AZ - Azerbaigian 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
EU - Europa 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
MT - Malta 1
NC - Nuova Caledonia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
PY - Paraguay 1
RO - Romania 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 4.942
Città #
Southend 437
Chandler 308
Dallas 215
Singapore 214
Woodbridge 198
Jacksonville 163
Ann Arbor 161
Hong Kong 151
Dublin 111
Ashburn 103
Verona 103
Beijing 56
Padova 56
Princeton 46
Lawrence 44
Milan 44
Munich 43
Wilmington 41
Houston 36
Helsinki 33
Nanjing 31
The Dalles 31
Shenyang 28
Jinan 25
Los Angeles 21
Tianjin 21
Boardman 17
New York 17
Zhengzhou 15
Columbus 14
Hebei 14
Lancaster 14
Sindelfingen 13
Taiyuan 13
Brussels 12
Buffalo 11
Guangzhou 11
Haikou 11
Hangzhou 10
Ningbo 10
Jakarta 9
Jiaxing 9
Lomé 9
Moscow 9
Norwalk 9
Redmond 9
Roverbella 9
San Francisco 9
Santa Clara 9
São Paulo 9
Taizhou 9
Changsha 8
Seattle 8
Afragola 7
Dong Ket 7
Nanchang 7
Belluno 6
Belo Horizonte 6
Frankfurt am Main 6
Limena 6
Lonigo 6
Redondo Beach 6
Rome 6
Romola 6
Washington 6
Ankara 5
Ballyvaghan 5
Bari 5
Boston 5
Brooklyn 5
Dearborn 5
Lanzhou 5
Montreal 5
San Giovanni Lupatoto 5
Auburn Hills 4
Campinas 4
Fairfield 4
Garbagnate Milanese 4
Manchester 4
Maple 4
Monteforte d'Alpone 4
Negrar 4
Phoenix 4
Redwood City 4
Reggio Calabria 4
Rio de Janeiro 4
Riyadh 4
Tappahannock 4
Trento 4
Venice 4
Vicenza 4
Vienna 4
Wuhan 4
York 4
Baghdad 3
Bologna 3
Braunschweig 3
Chennai 3
Chicago 3
Falls Church 3
Totale 3.235
Nome #
Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence 182
A Large Scale OLG Model for the Analysis of the Redistributive Effects of Policy Reforms 176
R&D and market size: who benefits from orphan drug regulation? 161
Public policies over the life cycle: a large scale OLG model for France, Italy and Sweden 154
A large scale OLG model for France, Italy and Sweden: assessing the interpersonal and intrapersonal redistributive effects of public policies 148
Redistribution at the Local Level: The Case of Public Childcare in Italy. University of Verona Department of Economics Working Paper 21/2013 (ISSN 2036-2919) 141
Redistribution at the Local Level: The Case of Public Childcare in Italy 139
Spillovers of Pharmaceutical Price Regulations: evidence from the AMNOG Reform in Germany 134
Public finance consolidation and fairness across living generations: the case of Italy. WP Series University of Verona Department of Economics (ISSN 2036-2919), 04/2012 127
L'ISEE in Italia: una nota metodologica partendo dai dati EU-SILC. University of Verona Department of Economics Working Paper 6/2014 (ISSN 2036-2919) 119
DRGs: the link between investment in technologies and appropriateness. WP Series University of Verona Department of Economics (ISSN 2036-2919), 31/2012 115
The dynamics of pharmaceutical regulation and R&D investments. WP Series University of Verona Department of Economics (ISSN 2036-2919), 4/2012 108
Dynamic, economic approaches to HTA under uncertainty. WP Series University of Verona Department of Economics (ISSN 2036-2919), 03/2011 106
Late-Stage Pharmaceutical R&D and Pricing Policies under Two-Stage Regulation 102
Drug Prices and Incentives to Innovation by the Pharmaceutical Industry 101
A Bayesian Decision-Theoretic Model of Sequential Experimentation with Delayed Response 101
The dynamics of pharmaceutical regulation and R&D investments 101
Two-part payments for the reimbursement of investments in health technologies 99
The timing of adoption of positron emission tomography:a real options approach 99
Optimal Decision Rules for HTA Under Uncertainty: a Wider, Dynamic Perspective 97
Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial 97
Late-Stage Pharmaceutical R&D and Pricing Policies under Two-Stage Regulation 95
Job Sick Leave: Detecting Opportunistic Behavior 95
Investimenti pubblici, risorse scarse: il ruolo dei diversi metodi di supporto alle decisioni 93
Optimal sequential sampling rules for the economic evaluation of health technologies 93
Who should monitor job sick leave? 91
An extension of the real option approach to the evaluation of health care technologies: the case of positron emission tomography 89
The fiscal disadvantage of young italians: a new view on consolidation and fairness 89
Investment in health technologies in a competitive model with real options 88
Technology adoption, quality and health care costs: a review of the literature 87
Optimal Bayesian sequential sampling rules for the economic evaluation of health technologies 87
Pricing policies when patients are heterogeneous: a welfare analysis 86
The impact of managed entry agreements on pharmaceutical prices 86
Efficienza e sostenibilità dell’intervento pubblico 85
A Bayesian Decision-Theoretic Model of Sequential Experimentation with Delayed Response 85
Static and dynamic effciency of irreversible health care investments under alternative payment rules 81
A reply to "Who would benefit from average value-based pricing?" 81
Which valued-based price when patients are heterogeneous? 79
R&D and market size: who benefits from orphan drug legislation? 79
Improving access to medicines and promoting pharmaceutical innovation 78
Is chest X-ray screening for lung cancer in smokers cost-effective? Evidence from a population-based study in Italy 76
Cost-effective clinical trial design: Application of a Bayesian sequential model to the ProFHER pragmatic trial 74
Static and Dynamic Efficiency of Irreversible Health Care investments under Alternative Payment Rules 72
Public health interventions: evaluating the economic evaluations 71
L’equità intergenerazionale delle politiche di bilancio 69
Strategic Interaction in Pharmaceutical Price Regulation: With or Without U? 67
Dynamic, incentive-compatible contracting for health services 67
A stepped-wedge randomised controlled trial to assess efficacy and cost-effectiveness of a care-bundle to prevent falls in older hospitalised patients 65
Authors' Reply to Garattini and Freemantle: "Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition" 64
Optimal Sequential Sampling with Delayed Observations and Unknown Variance 56
Valutare l’efficienza dei servizi ospedalieri in Italia: il caso delle aziende ospedaliero-universitarie 44
Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition 43
Totale 5.022
Categoria #
all - tutte 18.737
article - articoli 9.557
book - libri 0
conference - conferenze 310
curatela - curatele 353
other - altro 7.242
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.275
Totale 37.474


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021255 0 0 10 51 40 32 6 18 40 13 26 19
2021/2022422 30 70 13 6 19 17 18 25 41 13 66 104
2022/2023804 60 96 72 122 76 194 7 53 84 12 24 4
2023/2024435 18 30 31 72 47 57 27 38 10 16 53 36
2024/20251.183 57 90 67 195 32 32 31 102 162 82 103 230
2025/2026573 218 177 178 0 0 0 0 0 0 0 0 0
Totale 5.022